US2021054360A1PendingUtilityA1
Als inhibitor herbicide tolerant beta vulgaris mutants
Est. expiryOct 15, 2030(~4.2 yrs left)· nominal 20-yr term from priority
Inventors:Ruediger HainJuergen BentingGuenter DonnNathalie Knittel-OttlebenBernd HoltschulteAndreas LoockClemens SpringmannRudolf Jansen
C12N 15/8274A01H 5/06A01H 5/12A01H 6/024C12N 15/01C12N 5/04C12P 5/023Y02E50/30C12Y 401/03C07K 14/415C12P 7/10C12N 2502/99A01H 5/00Y02E50/10C12P 19/00A01H 1/06C12N 15/82C12N 9/88C12P 19/38A01H 1/04
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to an ALS inhibitor herbicide tolerant Beta vulgaris plant and parts thereof comprising a mutation of an endogenous acetolactate synthase (ALS) gene, wherein the ALS gene encodes an ALS polypeptide containing an amino acid different from tryptophan at a position 569 of the ALS polypeptide.
Claims
exact text as granted — not AI-modified1 . An ALS inhibitor herbicide tolerant Beta vulgaris plant and parts thereof comprising a mutation of an endogenous acetolactate synthase (ALS) gene, wherein the ALS gene encodes an ALS polypeptide containing an amino acid different from tryptophan at a position 569 of the ALS polypeptide.
2 . The Beta vulgaris plant and parts thereof according to claim 1 , in which the ALS polypeptide has at position 569 the amino acid alanine, glycine, isoleucine, leucine, methionine, phenylalanine, proline, valine, or arginine instead of the naturally encoded amino acid tryptophan.
3 . The Beta vulgaris plant and parts thereof according to claim 1 , wherein the ALS gene encodes an ALS polypeptide containing an amino acid different from tryptophan at a position 569 of the ALS polypeptide sequence as set forth in SEQ ID NO: 2.
4 . The Beta vulgaris plant and parts thereof according to claim 1 , in which the amino acid is leucine and in which the endogenous ALS gene is identical to the nucleotide sequence defined by SEQ ID NO: 3.
5 . The Beta vulgaris plant and parts thereof according to claim 1 , which are tolerant to one or more ALS-inhibitor herbicides belonging to the group consisting of sulfonylurea herbicides, sulfonylaminocarbonyltriazolinone herbicides, imidazolinone herbicides, triazolopyrimidine herbicides, and pyrimidinyl(thio)benzoate herbicides.
6 . The Beta vulgaris plant and parts thereof according to claim 1 , which are homozygous for the mutation of the endogenous acetolactate synthase (ALS) gene.
7 . The parts of the Beta vulgaris plant according to claim 1 , wherein the parts are organs, tissues, and cells of the plant, and preferably seeds.
8 . Method for the manufacture of the Beta vulgaris plant and the parts thereof of claim 1 , comprising the following steps:
(a) exposing calli from B. vulgaris , to about 10 −7 M-10 −9 M of an ALS inhibitor herbicide, preferably foramsulfuron; (b) selecting cell colonies which can grow in the presence of up to 3×10 −6 M of an ALS inhibitor herbicide, preferably foramsulfuron; (c) regenerating shoots in presence of an ALS inhibitor herbicide, preferably foramsulfuron; (d) selecting regenerated plantlets with an ALS inhibitor herbicide, preferably foramsulfuron, iodosulfuron-methyl-sodium and/or a mixture of both, wherein the dose of foramsulfuron is preferably equivalent to 7-70 g a.i./ha and the dose of iodosulfuron-methyl-sodium is preferably equivalent to 1-10 g a.i./ha.Join the waitlist — get patent alerts
Track US2021054360A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.